vs

Side-by-side financial comparison of Cushman & Wakefield Ltd. (CWK) and IQVIA (IQV). Click either name above to swap in a different company.

IQVIA is the larger business by last-quarter revenue ($4.4B vs $2.9B, roughly 1.5× Cushman & Wakefield Ltd.). IQVIA runs the higher net margin — 11.8% vs -0.8%, a 12.5% gap on every dollar of revenue. On growth, Cushman & Wakefield Ltd. posted the faster year-over-year revenue change (10.8% vs 10.3%). IQVIA produced more free cash flow last quarter ($561.0M vs $234.3M). Over the past eight quarters, Cushman & Wakefield Ltd.'s revenue compounded faster (15.5% CAGR vs 8.1%).

Cushman & Wakefield Inc. is an American global commercial real estate and property management services firm. The company's corporate headquarters is located in Chicago, Illinois. It is named after co-founders J. Clydesdale Cushman and Bernard Wakefield.

IQVIA Holdings, Inc., headquartered in Durham, North Carolina, is an American company focused on health information technology and clinical research.

CWK vs IQV — Head-to-Head

Bigger by revenue
IQV
IQV
1.5× larger
IQV
$4.4B
$2.9B
CWK
Growing faster (revenue YoY)
CWK
CWK
+0.6% gap
CWK
10.8%
10.3%
IQV
Higher net margin
IQV
IQV
12.5% more per $
IQV
11.8%
-0.8%
CWK
More free cash flow
IQV
IQV
$326.7M more FCF
IQV
$561.0M
$234.3M
CWK
Faster 2-yr revenue CAGR
CWK
CWK
Annualised
CWK
15.5%
8.1%
IQV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CWK
CWK
IQV
IQV
Revenue
$2.9B
$4.4B
Net Profit
$-22.4M
$514.0M
Gross Margin
Operating Margin
6.1%
14.4%
Net Margin
-0.8%
11.8%
Revenue YoY
10.8%
10.3%
Net Profit YoY
-119.8%
17.6%
EPS (diluted)
$-0.10
$2.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CWK
CWK
IQV
IQV
Q4 25
$2.9B
$4.4B
Q3 25
$2.6B
$4.1B
Q2 25
$2.5B
$4.0B
Q1 25
$2.3B
$3.8B
Q4 24
$2.6B
$4.0B
Q3 24
$2.3B
$3.9B
Q2 24
$2.3B
$3.8B
Q1 24
$2.2B
$3.7B
Net Profit
CWK
CWK
IQV
IQV
Q4 25
$-22.4M
$514.0M
Q3 25
$51.4M
$331.0M
Q2 25
$57.3M
$266.0M
Q1 25
$1.9M
$249.0M
Q4 24
$112.9M
$437.0M
Q3 24
$33.7M
$285.0M
Q2 24
$13.5M
$363.0M
Q1 24
$-28.8M
$288.0M
Gross Margin
CWK
CWK
IQV
IQV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
23.5%
Q2 24
22.6%
Q1 24
22.1%
Operating Margin
CWK
CWK
IQV
IQV
Q4 25
6.1%
14.4%
Q3 25
4.1%
13.5%
Q2 25
4.9%
12.6%
Q1 25
2.0%
13.0%
Q4 24
6.6%
15.8%
Q3 24
3.2%
14.1%
Q2 24
3.1%
13.6%
Q1 24
0.9%
13.5%
Net Margin
CWK
CWK
IQV
IQV
Q4 25
-0.8%
11.8%
Q3 25
2.0%
8.1%
Q2 25
2.3%
6.6%
Q1 25
0.1%
6.5%
Q4 24
4.3%
11.0%
Q3 24
1.4%
7.3%
Q2 24
0.6%
9.5%
Q1 24
-1.3%
7.7%
EPS (diluted)
CWK
CWK
IQV
IQV
Q4 25
$-0.10
$2.97
Q3 25
$0.22
$1.93
Q2 25
$0.25
$1.54
Q1 25
$0.01
$1.40
Q4 24
$0.49
$2.41
Q3 24
$0.14
$1.55
Q2 24
$0.06
$1.97
Q1 24
$-0.13
$1.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CWK
CWK
IQV
IQV
Cash + ST InvestmentsLiquidity on hand
$784.2M
$2.1B
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$2.0B
$6.5B
Total Assets
$7.7B
$29.9B
Debt / EquityLower = less leverage
1.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CWK
CWK
IQV
IQV
Q4 25
$784.2M
$2.1B
Q3 25
$634.4M
$2.0B
Q2 25
$618.2M
$2.2B
Q1 25
$623.2M
$1.9B
Q4 24
$793.3M
$1.8B
Q3 24
$775.4M
$1.7B
Q2 24
$567.3M
$1.7B
Q1 24
$553.5M
$1.6B
Total Debt
CWK
CWK
IQV
IQV
Q4 25
$2.7B
Q3 25
$2.8B
Q2 25
$3.0B
Q1 25
$3.0B
Q4 24
$3.0B
Q3 24
$3.1B
Q2 24
$3.1B
Q1 24
$3.2B
Stockholders' Equity
CWK
CWK
IQV
IQV
Q4 25
$2.0B
$6.5B
Q3 25
$2.0B
$6.2B
Q2 25
$1.9B
$5.8B
Q1 25
$1.8B
$6.0B
Q4 24
$1.8B
$6.1B
Q3 24
$1.7B
$7.0B
Q2 24
$1.6B
$6.7B
Q1 24
$1.6B
$6.3B
Total Assets
CWK
CWK
IQV
IQV
Q4 25
$7.7B
$29.9B
Q3 25
$7.7B
$28.7B
Q2 25
$7.6B
$28.6B
Q1 25
$7.4B
$27.3B
Q4 24
$7.5B
$26.9B
Q3 24
$7.5B
$27.2B
Q2 24
$7.3B
$26.4B
Q1 24
$7.5B
$26.6B
Debt / Equity
CWK
CWK
IQV
IQV
Q4 25
1.40×
Q3 25
1.45×
Q2 25
1.57×
Q1 25
1.70×
Q4 24
1.73×
Q3 24
1.81×
Q2 24
1.91×
Q1 24
1.96×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CWK
CWK
IQV
IQV
Operating Cash FlowLast quarter
$257.3M
$735.0M
Free Cash FlowOCF − Capex
$234.3M
$561.0M
FCF MarginFCF / Revenue
8.0%
12.9%
Capex IntensityCapex / Revenue
0.8%
4.0%
Cash ConversionOCF / Net Profit
1.43×
TTM Free Cash FlowTrailing 4 quarters
$293.0M
$2.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CWK
CWK
IQV
IQV
Q4 25
$257.3M
$735.0M
Q3 25
$235.5M
$908.0M
Q2 25
$9.6M
$443.0M
Q1 25
$-162.0M
$568.0M
Q4 24
$115.2M
$885.0M
Q3 24
$196.1M
$721.0M
Q2 24
$21.8M
$588.0M
Q1 24
$-125.1M
$522.0M
Free Cash Flow
CWK
CWK
IQV
IQV
Q4 25
$234.3M
$561.0M
Q3 25
$225.0M
$772.0M
Q2 25
$300.0K
$292.0M
Q1 25
$-166.6M
$426.0M
Q4 24
$105.9M
$721.0M
Q3 24
$186.7M
$571.0M
Q2 24
$10.0M
$445.0M
Q1 24
$-135.6M
$377.0M
FCF Margin
CWK
CWK
IQV
IQV
Q4 25
8.0%
12.9%
Q3 25
8.6%
18.8%
Q2 25
0.0%
7.3%
Q1 25
-7.3%
11.1%
Q4 24
4.0%
18.2%
Q3 24
8.0%
14.7%
Q2 24
0.4%
11.7%
Q1 24
-6.2%
10.1%
Capex Intensity
CWK
CWK
IQV
IQV
Q4 25
0.8%
4.0%
Q3 25
0.4%
3.3%
Q2 25
0.4%
3.8%
Q1 25
0.2%
3.7%
Q4 24
0.4%
4.1%
Q3 24
0.4%
3.9%
Q2 24
0.5%
3.7%
Q1 24
0.5%
3.9%
Cash Conversion
CWK
CWK
IQV
IQV
Q4 25
1.43×
Q3 25
4.58×
2.74×
Q2 25
0.17×
1.67×
Q1 25
-85.26×
2.28×
Q4 24
1.02×
2.03×
Q3 24
5.82×
2.53×
Q2 24
1.61×
1.62×
Q1 24
1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CWK
CWK

Equity Method Investment Nonconsolidated Investee Or Group Of Investees$1.8B61%
Other$1.1B39%

IQV
IQV

Segment breakdown not available.

Related Comparisons